MET and lung adenocarcinoma: This study established a mouse lung adenocarcinoma xenograft model, which was initially sensitive to VEGFR TKIs, but later developed resistance, as evidenced by tortuous tumor vasculature, and increased expression of stromal-derived HGF and activation of c-MET detected in cancer cells and tumor-associated mesenchyme.